Marcos A - Search Results

1

Millable polyurethane/organoclay nanocomposites: preparation, characterization, and properties.

Siliani M, López-Manchado MA, Valentín JL, Arroyo M, Marcos A, Khayet M, Villaluenga JP. Siliani M, et al. Among authors: marcos a. J Nanosci Nanotechnol. 2007 Feb;7(2):634-40. doi: 10.1166/jnn.2007.134. J Nanosci Nanotechnol. 2007. PMID: 17450806

2

Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease.

Silveyra MX, Cuadrado-Corrales N, Marcos A, Barquero MS, Rábano A, Calero M, Sáez-Valero J. Silveyra MX, et al. Among authors: marcos a. J Neurochem. 2006 Jan;96(1):97-104. doi: 10.1111/j.1471-4159.2005.03514.x. Epub 2005 Nov 8. J Neurochem. 2006. PMID: 16277609 Free article.

3

Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease.

Sáez-Valero J, Barquero MS, Marcos A, McLean CA, Small DH. Sáez-Valero J, et al. Among authors: marcos a. J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):664-7. doi: 10.1136/jnnp.69.5.664. J Neurol Neurosurg Psychiatry. 2000. PMID: 11032625 Free PMC article.

4

Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid.

Fodero LR, Sáez-Valero J, Barquero MS, Marcos A, McLean CA, Small DH. Fodero LR, et al. Among authors: marcos a. J Neurochem. 2001 Dec;79(5):1022-6. doi: 10.1046/j.1471-4159.2001.00640.x. J Neurochem. 2001. PMID: 11739614 Free article. Clinical Trial.

5

APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.

Barabash A, Marcos A, Ancín I, Vázquez-Alvarez B, de Ugarte C, Gil P, Fernández C, Encinas M, López-Ibor JJ, Cabranes JA. Barabash A, et al. Among authors: marcos a. Neurobiol Aging. 2009 Aug;30(8):1254-64. doi: 10.1016/j.neurobiolaging.2007.11.003. Epub 2007 Dec 19. Neurobiol Aging. 2009. PMID: 18078695

6

Importance of mesh overlap on hernia recurrence after open umbilical hernia repair with bilayer prosthesis.

Porrero JL, Cano-Valderrama O, Castillo MJ, Marcos A, Tejerina G, Cendrero M, Porrero B, Alonso MT, Torres AJ. Porrero JL, et al. Among authors: marcos a. Am J Surg. 2018 Nov;216(5):919-922. doi: 10.1016/j.amjsurg.2018.01.041. Epub 2018 Feb 2. Am J Surg. 2018. PMID: 29429547

7

Chorea as a form of presentation of human immunodeficiency virus-associated dementia complex.

Pardo J, Marcos A, Bhathal H, Castro M, Varea de Seijas E. Pardo J, et al. Among authors: marcos a. Neurology. 1998 Feb;50(2):568-9. doi: 10.1212/wnl.50.2.568. Neurology. 1998. PMID: 9484405 No abstract available.

8

Relevance of functional neuroimaging in the progression of mild cognitive impairment.

Cabranes JA, De Juan R, Encinas M, Marcos A, Gil P, Fernández C, De Ugarte C, Barabash A. Cabranes JA, et al. Among authors: marcos a. Neurol Res. 2004 Jul;26(5):496-501. doi: 10.1179/016164104225016155. Neurol Res. 2004. PMID: 15265266

9

Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease.

Marcos A, Gil P, Barabash A, Rodriguez R, Encinas M, Fernández C, Cabranes JA. Marcos A, et al. Am J Alzheimers Dis Other Demen. 2006 Jun-Jul;21(3):189-96. doi: 10.1177/1533317506289348. Am J Alzheimers Dis Other Demen. 2006. PMID: 16869340 Free PMC article.

10

The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.

Samaranch L, Cervantes S, Barabash A, Alonso A, Cabranes JA, Lamet I, Ancín I, Lorenzo E, Martínez-Lage P, Marcos A, Clarimón J, Alcolea D, Lleó A, Blesa R, Gómez-Isla T, Pastor P. Samaranch L, et al. Among authors: marcos a. J Alzheimers Dis. 2010;22(4):1065-71. doi: 10.3233/JAD-2010-101011. J Alzheimers Dis. 2010. PMID: 20930301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

787 results

Search Page